BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 7533489)

  • 1. [Phase III clinical trial for esophageal cancer using radiotherapy].
    Ogino T
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):341-9. PubMed ID: 7533489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy and multimodality therapy in the treatment of esophageal cancer].
    Ando N; Ozawa S; Kitajima M; Iizuka T
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):869-76. PubMed ID: 7540823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problems and present status of clinical trials for esophageal carcinoma].
    Hayashi K; Ide H
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():348-55. PubMed ID: 7986114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postoperative adjuvant therapies for esophageal carcinoma].
    Kuwano H; Ojima H; Kato H
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2023-7. PubMed ID: 11103232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
    Varadhachary G; Ajani JA
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress of postoperative adjuvant therapies for esophageal cancer].
    Terashima M; Kogure M; Gotoh M
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2475-80. PubMed ID: 12506469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma.
    Mooney MM
    J Surg Oncol; 2005 Dec; 92(3):230-8. PubMed ID: 16299790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant therapy of esophageal cancer.
    Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
    Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
    Shinoda M; Hatooka S; Mori S; Mitsudomi T
    Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical adjuvant therapy of carcinoma of the thoracic esophagus].
    Kakegawa T; Yamana H; Fujita H; Shinozaki K
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1173-8. PubMed ID: 8333745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.
    Glynne-Jones R; Mawdsley S; Novell JR
    Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of radiotherapy and chemotherapy in treatment of operable cancers of the esophagus].
    Msika S; Hay JM
    J Chir (Paris); 2002 Feb; 139(1):17-24. PubMed ID: 12071024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin, vindesine, pepleomycin and combined radiation therapy for inoperable esophageal carcinoma.
    Saito T; Kinoshita T; Shigemitsu Y; Shimoda K; Katsuta T; Miyahara M; Kobayashi M; Ashizawa A
    Jpn J Clin Oncol; 1993 Apr; 23(2):123-9. PubMed ID: 7685835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer.
    Blanke CD; Choy H; Teng M; Beauchamp RD; Leach S; Roberts J; Washington K; Johnson DH
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):43-52. PubMed ID: 10210539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preoperative synchronized chemoradiation therapy for advanced esophageal cancer].
    Tsujinaka T; Takami M; Takada T; Kitada M; Tsukahara Y; Shibata T; Niinobu T; Murotani M; Iihara K; Tsukamoto F; Ogawa M; Kimura M; Nose T
    Gan To Kagaku Ryoho; 1997 Mar; 24(5):557-61. PubMed ID: 9087287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.